Advances in the treatment of tuberculosis

Research output: Contribution to journalReview article


The current 6-month tuberculosis (TB) therapy is suboptimal with significant side effects and a poor patient compliance problem that frequently selects drug-resistant organisms. The increasing drug-resistant TB problem highlights the need to develop new and more effective drugs. Significant progress has been made recently with several new drug candidates currently in clinical trials. Improved understanding of persister biology and development of persister drugs are likely to be important for developing a more effective therapy.

Original languageEnglish (US)
Pages (from-to)595-600
Number of pages6
JournalClinical pharmacology and therapeutics
Issue number5
StatePublished - Nov 1 2007


ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Cite this